455 related articles for article (PubMed ID: 21994376)
21. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling.
Haj-Dahmane S; Shen RY
J Neurosci; 2005 Jan; 25(4):896-905. PubMed ID: 15673670
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptide S-initiated sequential cascade mediated by OX
Lee MT; Chiu YT; Chiu YC; Hor CC; Lee HJ; Guerrini R; Calo G; Chiou LC
J Biomed Sci; 2020 Jan; 27(1):7. PubMed ID: 31915019
[TBL] [Abstract][Full Text] [Related]
23. Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro.
Yu L; Zhang XY; Zhang J; Zhu JN; Wang JJ
Cerebellum; 2010 Mar; 9(1):88-95. PubMed ID: 19921532
[TBL] [Abstract][Full Text] [Related]
24. Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons.
Farkas I; Kalló I; Deli L; Vida B; Hrabovszky E; Fekete C; Moenter SM; Watanabe M; Liposits Z
Endocrinology; 2010 Dec; 151(12):5818-29. PubMed ID: 20926585
[TBL] [Abstract][Full Text] [Related]
25. Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.
Kushmerick C; Price GD; Taschenberger H; Puente N; Renden R; Wadiche JI; Duvoisin RM; Grandes P; von Gersdorff H
J Neurosci; 2004 Jun; 24(26):5955-65. PubMed ID: 15229243
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.
Aubrey KR; Drew GM; Jeong HJ; Lau BK; Vaughan CW
J Physiol; 2017 Jan; 595(1):165-178. PubMed ID: 27461371
[TBL] [Abstract][Full Text] [Related]
27. Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling.
Drew GM; Mitchell VA; Vaughan CW
J Neurosci; 2008 Jan; 28(4):808-15. PubMed ID: 18216189
[TBL] [Abstract][Full Text] [Related]
28. The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats.
Pourrahimi AM; Abbasnejad M; Raoof M; Esmaeili-Mahani S; Kooshki R
Peptides; 2021 Dec; 146():170651. PubMed ID: 34560171
[TBL] [Abstract][Full Text] [Related]
29. Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA.
Tjen-A-Looi SC; Li P; Longhurst JC
J Appl Physiol (1985); 2009 Jun; 106(6):1793-9. PubMed ID: 19325030
[TBL] [Abstract][Full Text] [Related]
30. Orexins/hypocretins: pain regulation and cellular actions.
Chiou LC; Lee HJ; Ho YC; Chen SP; Liao YY; Ma CH; Fan PC; Fuh JL; Wang SJ
Curr Pharm Des; 2010; 16(28):3089-100. PubMed ID: 20687883
[TBL] [Abstract][Full Text] [Related]
31. Targeting the cannabinoid system for pain relief?
Chiou LC; Hu SS; Ho YC
Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
[TBL] [Abstract][Full Text] [Related]
32. Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid.
Chou YH; Hor CC; Lee MT; Lee HJ; Guerrini R; Calo G; Chiou LC
Addict Biol; 2021 May; 26(3):e12971. PubMed ID: 33078457
[TBL] [Abstract][Full Text] [Related]
33. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system.
Palazzo E; de Novellis V; Petrosino S; Marabese I; Vita D; Giordano C; Di Marzo V; Mangoni GS; Rossi F; Maione S
Eur J Neurosci; 2006 Oct; 24(7):2011-20. PubMed ID: 17040473
[TBL] [Abstract][Full Text] [Related]
34. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model.
Palazzo E; Luongo L; Bellini G; Guida F; Marabese I; Boccella S; Rossi F; Maione S; de Novellis V
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):148-61. PubMed ID: 22483283
[TBL] [Abstract][Full Text] [Related]
35. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
36. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray.
Lau BK; Vaughan CW
Mol Pharmacol; 2008 Nov; 74(5):1392-8. PubMed ID: 18678620
[TBL] [Abstract][Full Text] [Related]
37. Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray.
Chen YH; Lee HJ; Lee MT; Wu YT; Lee YH; Hwang LL; Hung MS; Zimmer A; Mackie K; Chiou LC
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10720-E10729. PubMed ID: 30348772
[TBL] [Abstract][Full Text] [Related]
38. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K
Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
[TBL] [Abstract][Full Text] [Related]
39. Orexin affects dorsal root ganglion neurons: a mechanism for regulating the spinal nociceptive processing.
Yan JA; Ge L; Huang W; Song B; Chen XW; Yu ZP
Physiol Res; 2008; 57(5):797-800. PubMed ID: 18973425
[TBL] [Abstract][Full Text] [Related]
40. Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.
Drew GM; Lau BK; Vaughan CW
J Neurosci; 2009 Jun; 29(22):7220-9. PubMed ID: 19494144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
